Midazolam Hydrochloride Injection, Solution
Product Images NDC 68083-108

7 FDA label images from Gland Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Midazolam Hydrochloride (NDC 68083-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Midazolam-spl-structure-1 (Midazolam Spl Structure 1)

Midazolam-spl-structure-1 (Midazolam Spl Structure 1)
Chemical structure diagram of Midazolam Hydrochloride showing its molecular composition and arrangement of atoms, including chlorine (Cl), fluorine (F), and nitrogen (N) atoms, consistent with the Midazolam molecule complexed with hydrochloride (HCl).*
FDA Label Image

Midazolam-spl-structure-2 (Midazolam Spl Structure 2)

Midazolam-spl-structure-2 (Midazolam Spl Structure 2)
Chemical structure diagram showing the equilibrium between Midazolam and its open-ring form. The structures illustrate the molecular configurations of Midazolam, highlighting key functional groups and the transformation to the open-ring form.*
FDA Label Image

Midazolam-spl-figure (Midazolam Spl Figure)

Midazolam-spl-figure (Midazolam Spl Figure)
A line graph depicting the pH dependence of the open-ring form of a substance in water. The x-axis represents pH values ranging from 2.5 to 5.5, and the y-axis indicates the percentage of the open-ring form, decreasing steeply from about 52% to near 1% as pH increases.*
FDA Label Image

Midazolam-spl-5ml-vial (Midazolam Spl 5ml Vial)

Midazolam-spl-5ml-vial (Midazolam Spl 5ml Vial)
Midazolam Injection, USP 25 mg/5 mL (5 mg/mL) injection solution label for intramuscular or intravenous use. The 5 mL multiple-dose vial is labeled as sterile and contains benzyl alcohol as preservative. Manufactured by Gland Pharma Limited, Hyderabad, India. The label includes active ingredient concentration details and storage information.*
FDA Label Image

Midazolam-spl-5ml-carton (Midazolam Spl 5ml Carton)

Midazolam-spl-5ml-carton (Midazolam Spl 5ml Carton)
Box packaging label for Midazolam Injection, USP 25 mg/5 mL (5 mg/mL) by Gland Pharma Limited. The label indicates a pack of 10 multiple-dose vials, each vial containing 5 mL of solution for intramuscular or intravenous use. The label highlights that the solution contains benzyl alcohol as a preservative. Storage instructions and manufacturer details are also visible.*
FDA Label Image

Midazolam-spl-10ml-vial (Midazolam Spl 10ml Vial)

Midazolam-spl-10ml-vial (Midazolam Spl 10ml Vial)
Label for Midazolam Injection, USP at 5 mg/mL strength, presented as 50 mg in 10 mL multiple-dose vial. Intended for intramuscular or intravenous use. Contains benzyl alcohol as a preservative. Manufactured by Gland Pharma Limited, India. The label includes NDC 68083-108-02, sterile designation, and a barcode area.*
FDA Label Image

Midazolam-spl-10ml-carton (Midazolam Spl 10ml Carton)

Midazolam-spl-10ml-carton (Midazolam Spl 10ml Carton)
Packaging label for Midazolam Injection USP 50 mg/10 mL (5 mg/mL) by Gland Pharma Limited. The label indicates the product is a sterile injection solution containing benzyl alcohol, supplied in 10 x 10 mL multiple-dose vials. It is labeled for intramuscular or intravenous use, with storage instructions and manufacturer details included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.